The efficient synthesis of a new series of polyhydroxylated dibenzyl x-(1H-1,2,3-triazol-1yl)alkylphosphonates as acyclic nucleotide analogues is described starting from dibenzyl x-azido-(polyhydroxy)alkylphosphonates and selected alkynes under microwave irradiation. Selected O,O-dibenzylphosphonate acyclonucleotides were transformed into the respective phosphonic acids. All compounds were evaluated in vitro for activity against a broad variety of DNA and RNA viruses and for cytostatic activity against murine leukemia L1210, human T-lymphocyte CEM and human cervix carcinoma HeLa cells. Compound (1S,2S)-16b exhibited antiviral activity against Influenza A H3N2 subtype (EC 50 = 20 lM-visual CPE score; EC 50 = 18 lM-MTS method; MCC >100 lM, CC 50 >100 lM) in Madin Darby canine kidney cell cultures (MDCK), and (1S,2S)-16k was active against vesicular stomatitis virus and respiratory syncytial virus in HeLa cells (EC 50 = 9 and 12 lM, respectively). Moreover, compound (1R,2S)-16l showed activity against both herpes simplex viruses (HSV-1, HSV-2) in HEL cell cultures (EC 50 = 2.9 and 4 lM, respectively) and feline herpes virus in CRFK cells (EC 50 = 4 lM) but at the same time it exhibited cytotoxicity toward uninfected cell (MCC P 4 lM). Several other compounds have been found to inhibit proliferation of L1210, CEM as well as HeLa cells with IC 50 in the 4-50 lM range. Among them compounds (1S,2S)-and (1R,2S)-16l were the most active (IC 50 in the 4-7 lM range).
Introduction
Infectious diseases caused by different microorganisms such as bacteria, fungi and viruses, are still a problem of human civilization. Among all pathogenic microorganisms viruses are notorious, the most active and probably the most dangerous because they penetrate into cells, evolve rapidly and interfere with the genetic material of the host. Despite current achievements in the development of antiviral drugs, 1,2 there is still a need for new compounds with an unique mechanism of action and limited side-effects.
The successful search for acyclic nucleoside analogues started when acyclovir [9-(2-hydroxyethoxymethyl)guanine] was described as an antiherpesvirus agent. 3 Soon after, a few other acyclic nucleoside or acyclic nucleoside phosphonate analogues became available as antiviral compounds, namely, ganciclovir, cidofovir, tenofovir, adefovir, etc. 4, 5 Attempts to improve the solubility of compounds in aqueous media resulted in synthesis of hydroxylated analogues of nucleosides such as ganciclovir as well as other nucleoside mimetics shown on Figure 1 . 4, [6] [7] [8] [9] [10] [11] [12] [13] [14] The interest in investigation of hydroxylated nucleosides has also been stimulated by a previous discovery of extreme potency of the naturally accessible D-eritadenine 2, 7, 8 which acts as an inhibitor of S-adenosyl-L-homocysteine hydrolase (SAHH). This enzyme has earlier been shown to be an attractive target for poxviruses, (À)RNA viruses such as paramyxovirus and rhabdovirus, and (±)RNA viruses such as reovirus. 15, 16 Consequently, (2 0 S)-9-(2 0 ,3 0 -dihydroxypropyl)adenine 3 10 and other N(9)-substituted adenines and guanines possessing polyhydroxyalkyl chains have been obtained ( Fig. 1) .
Among various structural modifications of nucleosides/nucleotides 1,2,3-triazole analogues have been of special interest. The applicability of a 1,2,3-triazole ring as a replacement of sugar [17] [18] [19] or nucleobase moieties 17, [19] [20] [21] as well as an additional linker between a phosphonoalkyl unit and a nucleobase has been widely explored [22] [23] [24] [25] [26] [27] [28] including our achievements. [29] [30] [31] [32] [33] [34] [35] Recently, several http://dx.doi.org/10.1016/j.bmc.2014.05.020 0968-0896/Ó 2014 Elsevier Ltd. All rights reserved. acyclic 1,2,3-triazolyl analogues of nucleosides/nucleotides with nucleobases attached via the methylene group at the C4 in the 1,2,3-triazole moiety have been obtained and some of them showed promising biological activity (Fig. 2 ). While (1,2,3-triazol-1-yl)nucleosides 9-11 were found to be inactive against selected viruses, 22,23 the phosphonomethyl-12 (n = 1; B = Thy, Ade) and phosphonoethyl(1,2,3-triazoles) 12 (n = 2; R = Thy, Ura) showed moderate activity against hepatitis C virus (HCV). 25 Recently, we succeeded in the synthesis of 1-(3-phosphonopropyl)-1,2,3-triazole 13 substituted with benzoylbenzuracil via a methylene linker which exhibited activity against herpes simplex virus-1 (KOS), herpes simplex virus-2 (G) and feline herpes virus. 33 Moreover, the 1-(3-amino-3-phosphonopropyl)-1,2,3-triazole analogue (R)-14 having 3-acetylindole as a modified nucleobase showed moderate activity toward vesicular stomatitis virus. 35 In continuation of our research program towards 1,2,3-triazole nucleoside analogues, [14] [15] [16] [17] [18] [19] [20] [21] and taking into account the known biological activity of hydroxylated nucleoside analogues as well as the antiviral activity of 13 and 14 and the cytostatic properties of 15, 1,2,3-triazoles 16 and 17 possessing dibenzyloxyphosphono(polyhydroxy)alkyl residues have been designed ( Fig. 3 ). We assumed that incorporation of additional hydroxyl groups into an alkyl side-chain would assure better solubility and perhaps improve biological activity of 1,2,3-triazoles 16 and 17 in comparison with analogous compounds having unfunctionalised aliphatic moieties. 33 2. Results and discussion
Chemistry
Enantiomerically pure (1R,2S)-and (1S,2S)-azidophosphonates 18 were obtained from L-ascorbic acid, 36, 37 whereas for the synthesis of (1S,2R,3S)-and (1S,2R,3R)-azidophosphonates 19 38 tartaric acid and L-isoascorbic acid were used, respectively, as a source of chirality.
The 1,2,3-triazoles (1R,2S)-and (1S,2S)-16 were synthesised by the 1,3-dipolar cycloaddition of the corresponding (1R,2S)-and (1S,2S)-azidophosphonates 18 with N-propargyl nucleobases 20 (N 9 -propargyladenine 20a, 23 N 1 -propargylthymine 20b, 23 N 1 -propargyluracil 20c, 39 N 4 -acetyl-N 1 -propargylcytosine 20d 40 ) and several propargylated nucleobase mimetics 20 (N 1 -propargyl-6-azauracil 20e, 41 3-acetyl-N-propargylindole 20f, 42 N 1 -propargyltheobromine 20g, 43,44 N 7 -propargyltheophylline 20h, 45 8-chloro-N 7 -propargyltheophylline 20i, 46 N-propargyl-2-pyridone 20j, 47 N 3 -benzoyl-N 1 -propargyluracil 20k 33, 48 and N 3 -benzoyl-N 1 -propargylquinazolin-2,4dione 20l 33 ).
According to a standard protocol the regioselective formation of respective 1,4-disubstituted 1,2,3-triazoles was secured by the 1,3-dipolar cycloaddition of azides with terminal alkynes in the presence of a catalytic amount of Cu(I) at room temperature. 49, 50 However, under these conditions more than 3 days were required to complete the reaction of (1S,2S)-and (1R,2S)-azidophosphonates 18 with N-propargyl nucleobases 20. To accelerate the reaction the 1,3-dipolar cycloaddition was performed under microwave irradiation. Under these conditions the full conversion of azidophosphonates 18 into 1,2,3-triazoles 16 was observed at 40-45°C within 20 min (Scheme 1). In a similar way, employing (1S,2R,3S)-and (1S,2R,3R)-azidophosphonates 19 the corresponding 1,2,3-triazoles (1S,2R,3S)and (1S,2R,3R)-17 were successfully obtained (Scheme 2).
The compounds (1R,2S)-and (1S,2S)-16 as well as (1S,2R,3S)and (1S,2R,3R)-17 were obtained in good yields after purification by column chromatography on silica gel.
Selected dibenzyl phosphonates (1S,2S)-16 were subjected to hydrogenation in the presence of 10% Pd-C in aqueous methanol 37 to give the respective phosphonic acids 21 in good yields (Scheme 3).
Structures of all new compounds were confirmed on the basis of 1 H, 13 C, 31 P NMR and IR spectra data as well as by elemental analysis.
Antiviral activity and cytotoxicity evaluation
All the synthesised phosphonates (1R,2S)-and (1S,2S)-16 and (1S,2R,3S)-and (1S,2R,3R)-17 as well as the phosphonic acids (1S,2S)-21b and (1S,2S)-21k were evaluated for their antiviral activities against a wide variety of DNA and RNA viruses, using the following cell-based assays: (a) human embryonic lung (HEL) cells: herpes simplex virus-1 (KOS), herpes simplex virus-2 (G), herpes simplex virus-1 (TK ACV r KOS), vaccinia virus and vesicular stomatitis virus, cytomegalovirus (AD-169 strain and Davis strain), The cytotoxicity of the tested compounds toward the uninfected host cells was defined as the minimum cytotoxic concentration (MCC) that causes a microscopically detectable alteration of normal cell morphology. The 50% cytotoxic concentration (CC 50 ), causing a 50% decrease in cell viability was determined using a colorimetric 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay system.
It was established that compound (1S,2S)-16b containing a 1,2,3-triazole moiety substituted at C4 0 with thymine exhibited antiviral activity against Influenza A H3N2 subtype (EC 50 = 20 lM by visual CPE score; EC 50 = 18 lM by MTS score; MCC >100 lM, CC 50 >100 lM) in Madin Darby canine kidney cells (MDCK). On the other hand, compound (1S,2S)-16k with N 3 -benzoyluracil showed antiviral activity against vesicular stomatitis virus (EC 50 = 9 lM) and respiratory syncytial virus (EC 50 = 12 lM) in HeLa cells which favourably compares with the data for ribavirin (EC 50 = 17 and 5 lM, respectively). Moreover, compound (1R,2S)-16l containing the N 3 -benzoylbenzuracil moiety showed activity against both herpes simplex viruses (HSV-1, HSV-2) in HEL cell cultures (EC 50 = 2.9 and 4 lM, respectively) and feline herpes virus in CRFK cells (EC 50 = 4 lM) but at the same time it exhibited cytotoxicity toward uninfected cell cultures (MCC P 4 lM). Moreover, compound (1S,2S)-16e was slightly active against both TK + VZV and TK VZV strains (EC 50 = 63.7 and 70 lM, respectively), whereas (1S,2R,3R)-17i showed activity against the TK + VZV strain only (EC 50 = 55.7 lM).
Evaluation of cytostatic activity
The cytostatic activity of the tested compounds was defined as the 50% cytostatic inhibitory concentration (IC 50 ), causing a 50% decrease in cell proliferation and was determined against murine Table 1 . Several compounds were endowed with a cytostatic activity at compound concentrations below 50 lM [i.e., (1S,2S)-16i-l and (1R,2S)-16f-l] toward tested tumor cell lines, namely, L1210,CEM and HeLa. Among all tested compounds, 1,2-dihydroxypropylphosphonates (1S,2S)and (1R,2S)-16l, both having N 3 -benzoylbenzuracil as a modified nucleobase, were the most potent and showed cytostatic activity between 4 and 7 lM toward the tested tumor cell lines (Table 1 ).
Structure-activity relationship studies
As far as cytostatic properties are considered, within a series of hydroxylated ( 33 and the inactive propylphosphonate 13. 33 As could be expected highly polar phosphonic acid (1S,2S)-21k showed no cytostatic activity while much more lipophilic O,O-dibenzyl ester (1S,2S)-16k was moderately active.
Analogous structure-antiviral activity relationship studies on a series of (1,2,3-triazol-1-yl)nucleotide analogues 16 and 17 were performed.
Thus, 1-hydroxy-2-benzyloxypropylphosphonate (1R,2S)-16l, which contains a N 3 -benzoylbenzyuracil residue, showed promising antiviral activity against herpes simplex viruses (HSV-1, HSV-2) in HEL cell cultures (EC 50 = 2.9 and 4 lM, respectively) and feline herpes virus in CRFK cells (EC 50 = 4 lM), whereas its N 3 -benzoyluracil and uracil analogues (1R,2S)-16k and (1R,2S)-16c, respectively, appeared inactive. This trend well correlates with our previous observations on structurally analogous (1,2,3-triazol-1-yl)nucleotides having an unsubstituted phosphonopropyl chain, since compound 13 was the most active against HSV-1, HSV-2 (EC 50 = 17 lM) and against feline herpes virus (EC 50 = 24 lM). 33 Furthermore, the stereochemistry of the aliphatic chain substituted with hydroxyl groups is essential for activity since analogue (1S,2S)-16l showed no activity. On the other hand, the significant activity toward vesicular stomatitis virus and respiratory syncytial virus in HeLa cell cultures was observed for compound (1S,2S)-16k containing an N 3 -benzoyluracil unit (EC 50 = 9 and 12 lM, respectively) since analogous compounds (1S,2S)-16l (B = N 3 -benzoylbenzuracil) and (1S,2S)-16c (B = uracil) were inactive against these viruses. Again, stereochemistry of an aliphatic fragment appeared important and resulted in lack of activity for (1R,2S)-16k. 1 H NMR were taken in CDCl 3 or CD 3 OD on the following spectrometers: Varian Mercury-300 and Bruker Avance III (600 MHz) with TMS as an internal standard; chemical shifts d in ppm with respect to TMS; coupling constants J in Hz. 13 C NMR spectra were recorded for CDCl 3 ,CD 3 OD or DMSO-d 6 solutions on a Varian Mercury-300 and Bruker Avance III (600 MHz) spectrometer at 75.5 and 150.5 MHz, respectively. 31 P NMR spectra were taken in CDCl 3 or CD 3 OD on Varian Mercury-300 and Bruker Avance III at 121.5 and 242 MHz.
Conclusions
(1R,2S)-16k N 3 -Benzoyluracil 21 ± 1 21 ± 1 57 ± 33 (1R,2S)-16l N 3 -Benzoylbenzuracil 4.7 ± 0.1 4.7 ± 0.3 5.1 ± 3.2 (1S,2R,3S)-17a Adenine >200 >200 >200 (1S,2R,3S)-17b Thymine >200 139 ± 46 107 ± 37 (1S,2R,3S)-17c Uracil >200 >200 118 ± 16 (1S,2R,3S)-17d N 4 -Acetylcytosine >200 >200 >200 (1S,2R,3S)-17g Theobromine 142 ± 40 145 ± 0 >200 (1S,2R,3S)-17i 8-Chlorotheophylline >200 >200 >200 (1S,2R,3R)-17a Adenine 140 ± 49 98 ± 3.5 P167 (1S,2R,3R)-17b Thymine >200 122 ± 21 P200 (1S,2R,3R)-17c Uracil >200 >200 >200 (1S,2R,3R)-17d N 4 -Acetylcytosine >200 >200 >200 (1S,2R,3R)-17g
Experimental section
IR spectral data were measured on an Infinity MI-60 FT-IR spectrometer. Melting points were determined on a Boetius apparatus and are uncorrected. Elemental analyses were performed by the Microanalytical Laboratory of this Faculty on a Perkin Elmer PE 2400 CHNS analyzer. Polarimetric measurements were conducted on an Optical Activity PolAAr 3001 apparatus.
The following adsorbents were used: column chromatography, Merck silica gel 60 (70-230 mesh); analytical TLC, Merck TLC plastic sheets silica gel 60 F 254 . TLC plates were developed in chloroformmethanol solvent systems. Visualization of the spots was effected with iodine vapours. All solvents were purified by methods described in the literature.
All microwave irradiation experiments were carried out in a microwave reactor Plazmartonika RM 800. The reaction carried out in 50 mL-glass vials. 
